Why the study?
Does genetic manipulation of adiponectin levels prevent atherosclerotic plaque formation in Ldlr(-/-) and Apoe(-/-) mouse models?
Population
Adiponectin knockout mice (Adn) or mice with chronically elevated adiponectin levels (Adn) crossed into…
Comparison
Genetic knockout or overexpression of adiponectin vs Control mice with normal adiponectin levels
Design
Preclinical
Authors
Loading...
Adiponectin modulation does not affect plaque in these mouse models; leaves open its causal role in human atherosclerosis.
Does genetic manipulation of adiponectin levels prevent atherosclerotic plaque formation in Ldlr(-/-) and Apoe(-/-) mouse models?
In preclinical mouse models, genetic gain- or loss-of-function of adiponectin had no direct impact on atherosclerotic plaque formation, suggesting a lack of causation despite human associations.
Nawrocki et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: